Weekly News Round-up – 29/1/21

In the news this week, the ongoing dispute between the UK and European Commission over vaccines entering the UK could lead to two months’ delay in herd immunity and thousands of deaths if EU plans go through. In other news,...

1 month ago
R&D,Bioprocess,Weekly Roundups,Biology,News

Weekly News Round-up – 29/1/21

In the news this week, the ongoing dispute between the UK and European Commission over vaccines entering the UK could lead to two months’ delay in herd immunity and thousands of deaths if EU plans go through. In other news,...

1 month ago

Weekly News Round-up – 22/1/21

In the news this week, collaboration within the pharma industry continues to struggle as it is revealed that the WHO’s platform for industry collaboration over COVID-19 goes entirely unused. In other news, Merck finally loses its hepatitis C patent infringement...

1 month ago
R&D,Bioprocess,Clinical Development,Weekly Roundups,News

Weekly News Round-up – 22/1/21

In the news this week, collaboration within the pharma industry continues to struggle as it is revealed that the WHO’s platform for industry collaboration over COVID-19 goes entirely unused. In other news, Merck finally loses its hepatitis C patent infringement...

1 month ago

The Importance of Efficacy in COVID-19 Vaccines

With a number of competing vaccines rapidly rolling out around the world, for many COVID-19 seems an already receding issue. The leading vaccines - from AstraZeneca/University of Oxford, from Pfizer and from Moderna - are in the process of manufacturing...

2 months ago
R&D,Clinical Development,Clinical Operations,Biology,News

The Importance of Efficacy in COVID-19 Vaccines

With a number of competing vaccines rapidly rolling out around the world, for many COVID-19 seems an already receding issue. The leading vaccines - from AstraZeneca/University of Oxford, from Pfizer and from Moderna - are in the process of manufacturing...

2 months ago

Weekly News Round-up – 15/1/21

In the news this week, COVID vaccine production continues to advance, with Regeneron signing a new $2.6 billion deal in the US, the J&J one-shot looks set to distribute in March 2021, and two inhaler treatments advance in trials. In...

2 months ago
R&D,Bioprocess,Clinical Development,Weekly Roundups,News

Weekly News Round-up – 15/1/21

In the news this week, COVID vaccine production continues to advance, with Regeneron signing a new $2.6 billion deal in the US, the J&J one-shot looks set to distribute in March 2021, and two inhaler treatments advance in trials. In...

2 months ago

Clinical Challenges Facing Pharma Over the Next Five Years

With 2020 shaking up the pharma industry and ushering in a wealth of new technologies, ideas and processes, the future seems more uncertain than ever. Given the sheer number of new challenges and obstacles to overcome in the clinical sector,...

2 months ago
Biology

Clinical Challenges Facing Pharma Over the Next Five Years

With 2020 shaking up the pharma industry and ushering in a wealth of new technologies, ideas and processes, the future seems more uncertain than ever. Given the sheer number of new challenges and obstacles to overcome in the clinical sector,...

2 months ago

Weekly News Round-up – 8/1/21

Vaccines dominate the news this week, as multiple companies come ever closer to having their products greenlit for market. Janssen’s single-shot vaccine could be approved within weeks, while Moderna’s vaccine sees EU take-up and AZ/Oxford University’s product seems set for...

2 months ago
R&D,Bioprocess,Clinical Development,Weekly Roundups,News

Weekly News Round-up – 8/1/21

Vaccines dominate the news this week, as multiple companies come ever closer to having their products greenlit for market. Janssen’s single-shot vaccine could be approved within weeks, while Moderna’s vaccine sees EU take-up and AZ/Oxford University’s product seems set for...

2 months ago
Previous Page Showing 12 out of 78 Next Page
Working With us

Interested?
Reserve your space